Skip to main content
Fig. 5 | BMC Complementary Medicine and Therapies

Fig. 5

From: Revealing the potential mechanism of Astragalus membranaceus improving prognosis of hepatocellular carcinoma by combining transcriptomics and network pharmacology

Fig. 5

Astragalus membranaceus targeted MT1G by daidzein. A Astragalus membranaceus-component−target network showed that Astragalus membranaceus targeted MT2A by daidzein. Red dots represent components, and blue spots represent targets. B The identity analysis of sequence (mRNA and protein) and function (GO) showed that MT1G and MT2A are highly similar and homologous

Back to article page